Literature DB >> 22553325

A human coronavirus responsible for the common cold massively kills dendritic cells but not monocytes.

Mariana Mesel-Lemoine1, Jean Millet, Pierre-Olivier Vidalain, Helen Law, Astrid Vabret, Valérie Lorin, Nicolas Escriou, Matthew L Albert, Béatrice Nal, Frédéric Tangy.   

Abstract

Human coronaviruses are associated with upper respiratory tract infections that occasionally spread to the lungs and other organs. Although airway epithelial cells represent an important target for infection, the respiratory epithelium is also composed of an elaborate network of dendritic cells (DCs) that are essential sentinels of the immune system, sensing pathogens and presenting foreign antigens to T lymphocytes. In this report, we show that in vitro infection by human coronavirus 229E (HCoV-229E) induces massive cytopathic effects in DCs, including the formation of large syncytia and cell death within only few hours. In contrast, monocytes are much more resistant to infection and cytopathic effects despite similar expression levels of CD13, the membrane receptor for HCoV-229E. While the differentiation of monocytes into DCs in the presence of granulocyte-macrophage colony-stimulating factor and interleukin-4 requires 5 days, only 24 h are sufficient for these cytokines to sensitize monocytes to cell death and cytopathic effects when infected by HCoV-229E. Cell death induced by HCoV-229E is independent of TRAIL, FasL, tumor necrosis factor alpha, and caspase activity, indicating that viral replication is directly responsible for the observed cytopathic effects. The consequence of DC death at the early stage of HCoV-229E infection may have an impact on the early control of viral dissemination and on the establishment of long-lasting immune memory, since people can be reinfected multiple times by HCoV-229E.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22553325      PMCID: PMC3416289          DOI: 10.1128/JVI.00269-12

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  50 in total

1.  Identification of DC-SIGN, a novel dendritic cell-specific ICAM-3 receptor that supports primary immune responses.

Authors:  T B Geijtenbeek; R Torensma; S J van Vliet; G C van Duijnhoven; G J Adema; Y van Kooyk; C G Figdor
Journal:  Cell       Date:  2000-03-03       Impact factor: 41.582

2.  Measles virus induces abnormal differentiation of CD40 ligand-activated human dendritic cells.

Authors:  C Servet-Delprat; P O Vidalain; H Bausinger; S Manié; F Le Deist; O Azocar; D Hanau; A Fischer; C Rabourdin-Combe
Journal:  J Immunol       Date:  2000-02-15       Impact factor: 5.422

3.  Characterization of human blood dendritic cell subsets.

Authors:  Kelli P A MacDonald; David J Munster; Georgina J Clark; Andrzej Dzionek; Juergen Schmitz; Derek N J Hart
Journal:  Blood       Date:  2002-08-15       Impact factor: 22.113

4.  In vitro detection of apoptosis in monocytes/macrophages infected with human coronavirus.

Authors:  Arlene R Collins
Journal:  Clin Diagn Lab Immunol       Date:  2002-11

5.  Vaccinia virus inhibits the maturation of human dendritic cells: a novel mechanism of immune evasion.

Authors:  J Engelmayer; M Larsson; M Subklewe; A Chahroudi; W I Cox; R M Steinman; N Bhardwaj
Journal:  J Immunol       Date:  1999-12-15       Impact factor: 5.422

6.  Reduced blood CD123+ (lymphoid) and CD11c+ (myeloid) dendritic cell numbers in primary HIV-1 infection.

Authors:  J Pacanowski; S Kahi; M Baillet; P Lebon; C Deveau; C Goujard; L Meyer; E Oksenhendler; M Sinet; A Hosmalin
Journal:  Blood       Date:  2001-11-15       Impact factor: 22.113

7.  Neuroinvasion by human respiratory coronaviruses.

Authors:  N Arbour; R Day; J Newcombe; P J Talbot
Journal:  J Virol       Date:  2000-10       Impact factor: 5.103

8.  Consequences of Fas-mediated human dendritic cell apoptosis induced by measles virus.

Authors:  C Servet-Delprat; P O Vidalain; O Azocar; F Le Deist; A Fischer; C Rabourdin-Combe
Journal:  J Virol       Date:  2000-05       Impact factor: 5.103

9.  Frontline: Induction of apoptosis and modulation of c-FLIPL and p53 in immature dendritic cells infected with herpes simplex virus.

Authors:  Dagmar B Müller; Martin J Raftery; Angela Kather; Thomas Giese; Günther Schönrich
Journal:  Eur J Immunol       Date:  2004-04       Impact factor: 5.532

10.  Coronavirus-related nosocomial viral respiratory infections in a neonatal and paediatric intensive care unit: a prospective study.

Authors:  A Gagneur; J Sizun; S Vallet; M C Legr; B Picard; P J Talbot
Journal:  J Hosp Infect       Date:  2002-05       Impact factor: 3.926

View more
  48 in total

1.  Cytopathic Effect Assay and Plaque Assay to Evaluate in vitro Activity of Antiviral Compounds Against Human Coronaviruses 229E, OC43, and NL63.

Authors:  Yanmei Hu; Chunlong Ma; Jun Wang
Journal:  Bio Protoc       Date:  2022-02-05

2.  Hematopoietic cancer cell lines can support replication of Sabin poliovirus type 1.

Authors:  Dinja Oosterhoff; Gerard van de Weerd; Gerco van Eikenhorst; Tanja D de Gruijl; Leo A van der Pol; Wilfried A M Bakker
Journal:  Biomed Res Int       Date:  2015-02-28       Impact factor: 3.411

Review 3.  A review of genetic methods and models for analysis of coronavirus-induced severe pneumonitis.

Authors:  Brenna McGruder; Julian L Leibowitz
Journal:  J Gen Virol       Date:  2014-09-24       Impact factor: 3.891

4.  Original Chemical Series of Pyrimidine Biosynthesis Inhibitors That Boost the Antiviral Interferon Response.

Authors:  Marianne Lucas-Hourani; Daniel Dauzonne; Hélène Munier-Lehmann; Samira Khiar; Sébastien Nisole; Julien Dairou; Olivier Helynck; Philippe V Afonso; Frédéric Tangy; Pierre-Olivier Vidalain
Journal:  Antimicrob Agents Chemother       Date:  2017-09-22       Impact factor: 5.191

Review 5.  Human Coronaviruses: A Review of Virus-Host Interactions.

Authors:  Yvonne Xinyi Lim; Yan Ling Ng; James P Tam; Ding Xiang Liu
Journal:  Diseases       Date:  2016-07-25

Review 6.  A rational roadmap for SARS-CoV-2/COVID-19 pharmacotherapeutic research and development: IUPHAR Review 29.

Authors:  Steve P H Alexander; Jane F Armstrong; Anthony P Davenport; Jamie A Davies; Elena Faccenda; Simon D Harding; Francesca Levi-Schaffer; Janet J Maguire; Adam J Pawson; Christopher Southan; Michael Spedding
Journal:  Br J Pharmacol       Date:  2020-07-19       Impact factor: 8.739

Review 7.  A contemporary review on pathogenesis and immunity of COVID-19 infection.

Authors:  Rasoul Mirzaei; Sajad Karampoor; Mohammad Sholeh; Pouya Moradi; Reza Ranjbar; Faezeh Ghasemi
Journal:  Mol Biol Rep       Date:  2020-06-29       Impact factor: 2.316

Review 8.  Clinical-Pathological Correlation of the Pathophysiology and Mechanism of Action of COVID-19 - a Primer for Clinicians.

Authors:  Jeremy Chee; Woei Shyang Loh; Zheng Liu; Joaquim Mullol; De Yun Wang
Journal:  Curr Allergy Asthma Rep       Date:  2021-07-14       Impact factor: 4.806

Review 9.  Control of Innate Immune Activation by Severe Acute Respiratory Syndrome Coronavirus 2 and Other Coronaviruses.

Authors:  Thomas Kehrer; Adolfo García-Sastre; Lisa Miorin
Journal:  J Interferon Cytokine Res       Date:  2021-06       Impact factor: 3.657

10.  Human coronavirus HKU1 infection of primary human type II alveolar epithelial cells: cytopathic effects and innate immune response.

Authors:  Samuel R Dominguez; Emily A Travanty; Zhaohui Qian; Robert J Mason
Journal:  PLoS One       Date:  2013-07-24       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.